<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>BioC-API</source><date>20250921</date><key>collection.key</key><document><id>PMC12040010</id><infon key="license">CC BY</infon><passage><infon key="article-id_art-access-id">00045</infon><infon key="article-id_doi">10.1097/MD.0000000000042125</infon><infon key="article-id_pmc">PMC12040010</infon><infon key="article-id_pmid">40295272</infon><infon key="article-id_publisher-id">MD-D-24-08638</infon><infon key="elocation-id">e42125</infon><infon key="issue">17</infon><infon key="kwd">case report central nervous system infection cryptococcal meningitis Cryptococcus albidus liposomal-amphotericin B review</infon><infon key="license">This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon><infon key="name_0">surname:Wang;given-names:Genzhu</infon><infon key="name_1">surname:Liu;given-names:Hang</infon><infon key="name_2">surname:Wang;given-names:Xiaoying</infon><infon key="name_3">surname:Li;given-names:Zhongdong</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">104</infon><infon key="year">2025</infon><offset>0</offset><text> Cryptococcus albidus meningitis: A case report and literature review</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>70</offset><text>Rationale:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>81</offset><text>Central nervous system (CNS) infections caused by Cryptococcus albidus are rarely reported, but are often associated with high mortality rates. Clinical data on the appropriate use of liposomal-amphotericin B (liposomal-AmB) with cryptococcal meningitis are limited. Here, we report for the first time the efficacious and safe use of the ideal bodyweight to calculate the dose of liposomal-AmB for a severely obese patient with C albidus meningitis. We also review the cases of CNS infection caused by C albidus and its related species.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>618</offset><text>Patient concerns:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>636</offset><text>A severely obese female patient was admitted to neurosurgical ward with lesions in the intracranial space and accompanying headache. Brain magnetic resonance imaging revealed prominent lesions in the right parietal and left frontal insular region. After glioma resection, C albidus was isolated from her cerebrospinal fluid samples.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>969</offset><text>Diagnoses, interventions, and outcomes:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1009</offset><text>She diagnosed histopathologically with a Cryptococcus species infection. The culture from her cerebrospinal fluid sample showed the growth of yeast-like colonies, which were identified as C albidus with mass spectrometry. She was treated with liposomal-AmB (50 mg day-1 intravenously) plus 5-fluorocytosine (10 g day-1 orally in 4 divided doses) for 6 weeks. The patient was asymptomatic at the time of discharge.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1427</offset><text>Lessons:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1436</offset><text>CNS infections of C albidus were uncommon. Using ideal bodyweight to calculate the dose of liposomal-AmB should be considered for severely obese patients with C albidus meningitis.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1617</offset><text>1. Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1633</offset><text>Central nervous system (CNS) infections of Cryptococcus species are life-threatening diseases. C albidus, also called Naganishia albida, was first reported to infect humans in 1965, and several opportunistic infections associated with C albidus have since been reported. To date, the yeast has been isolated from the cerebrospinal fluid (CSF), lung abscesses, pleural fluids, and blood specimens of patients. Of those invasive infections, 30% of the patients had a CNS infections. Most notably, the mortality rate was 67% in patients with CNS infections caused by C albidus, which is more than double that of patients infected with other Cryptococcus species. Although fewer than 10 cases of C albidus infection have been reported, the fungus has received attention because its mortality rate is high. Here, we report a clinical case of cryptococcal meningitis caused by C albidus. Clinically isolated C albidus may include many other related species, for example, C adeliensis and C diffluent. No clear-cut epidemiological markers have been described to determine the likelihood of C albidus. Recommended guidelines for its treatment are also lacking. Therefore, it is extremely important to identify the risk factors, clinical presentation, diagnosis, and treatment for CNS infection due to C albidus and its related species.</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">title_1</infon><offset>2961</offset><text>2. Case presentation</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">paragraph</infon><offset>2982</offset><text>A 25-year-old female patient (height was 158 cm, bodyweight was 100 kg) was admitted to Beijing Electric Power Hospital (Beijing, China) in March, 2022 with lesions in the intracranial space and accompanying headache. Six months before admission to the hospital, she had undergone successful left temporoparietal occipital craniotomy and decompressive craniectomy. Afterwards, she subsequently suffered intermittent headache, concurrently with nausea and disordered consciousness, and was treated with mannitol and levetiracetam before her admission. The patient denied any family or medical history, except invasive procedures of her CNS 6 months previously. She was a farmer, in frequent contact with cats and dogs. A physical examination revealed no unusual findings. Specifically, her body temperature was 36 °C, blood pressure 130/70 mm Hg, pulse rate 68 beats/min, and respiratory rate 17 breaths/min. Brain magnetic resonance imaging revealed prominent lesions in the right parietal accompanied by moderate edema and left frontal insular region with mild edema. The lesion volume in the right parietal region and the left frontal insular was about 4 × 4 × 3 cm3 and 3 × 3 × 3 cm3, respectively (Fig. 1).</text></passage><passage><infon key="file">medi-104-e42125-g001.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>4224</offset><text>Brain magnetic resonance imaging (MRI) scan of the patient before surgery. A type of circular lesion was observed in the right parietal lobe with long signals on T1-weighted (A) and T2-weighted (B) images. The lesion was about 4 × 4 × 3 cm3 in size (red arrow) and accompanied by moderate edema of surrounding brain tissue (yellow arrow). Another type of circular lesion was deep in the left frontal lobe, with long signals on T1-weighted (A) and T2-weighted (B) images. The lesion was about 3 × 3 × 3 cm3 in size (red arrow) and accompanied by mild edema (yellow arrow). Enhanced MRI scanning showed that the lesions were unevenly and significantly enhanced (C).</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">paragraph</infon><offset>4912</offset><text>On day 0 (admission), the patient’s associated laboratory data were normal. Specifically, her white blood cell count was 9.5 × 109 L-1; neutrophils, lymphocytes, and monocytes accounted for 73.8%, 21.1%, and 4.9%, respectively. Her red blood cell count was 4.4 × 1012 L-1, hemoglobin level was 133.0 g L-1, and platelet count was 213.0 × 109 L-1. Urinalysis, hepatic and renal function tests were normal. During hospitalization, no chemotherapy and/or other immunosuppressive drug was administered. On day 5 after admission, the patient underwent right parieto-occipital for glioma resection. However, her headache persisted.</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">paragraph</infon><offset>5557</offset><text>In the postoperative period, the patient experienced seizures, treated with mannitol and valproic acid. On day 14, she was diagnosed histopathologically with a Cryptococcus species infection. On day 16, the culture from her CSF sample showed the growth of yeast-like colonies, which were identified as C albidus with VITEK mass spectrometry (BioMerieux, France). To date, no Clinical and Laboratory Standards Institute clinical breakpoints or epidemiological cutoff values have been established for C albidus. The susceptibility of the pathogen to 5 antifungal compounds was tested in accordance with the guidelines of Clinical and Laboratory Standards Institute document M27-A3. The minimal inhibitory concentrations of amphotericin B (AmB), fluconazole, voriconazole, itraconazole, and 5-fluorocytosine for C albidus were determined to be 0.5, 4, 1, 0.125, and 4 mg L-1, respectively.</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">paragraph</infon><offset>6446</offset><text>After the patient was diagnosed with a Cryptococcus species infection, she was administered with of liposomal-AmB (50 mg day-1 intravenously) qd plus 5-fluorocytosine (10 g day-1 orally in 4 divided doses) for 6 weeks. Her magnetic resonance imaging results showed that only the left frontal insular region still had a lesion, with otherwise normal parenchyma, after 3 weeks of treatment (Fig. 2). In addition, no yeast was isolated from 3 different CSF samples after 4 weeks of treatment (Table 1). The patient maintained normal renal function during the entire treatment period (Fig. 3). On day 48 after admission, the patient stopped complaining of headache, and suffered no further nausea or consciousness disorder. The patient was asymptomatic at the time of discharge, with normal glucose, protein, and lactate levels in the CSF.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>7286</offset><text>Analysis of cerebrospinal fluid.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;2&quot; colspan=&quot;1&quot;&gt;Hospitalization days&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Glucose&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chloride&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Microalbumin&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;2&quot; colspan=&quot;1&quot;&gt;Color&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;2&quot; colspan=&quot;1&quot;&gt;Turbidity&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;2&quot; colspan=&quot;1&quot;&gt;Pandy test&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Red blood cells&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;White blood cells&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Neutrophil&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lymphocyte&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;2&quot; colspan=&quot;1&quot;&gt;Culture&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;mmol/L&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;mmol/L&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;mg/L&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;/mm&lt;sup&gt;3&lt;/sup&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;/mm&lt;sup&gt;3&lt;/sup&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;%&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;%&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3/16&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.88&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;118.2&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;80&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Colorless&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Clear&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Positive&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;106&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;22&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;78&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3/21&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.32&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;123&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;95&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Colorless&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Slightly turbid&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Positive&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1000&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;339&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;64&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;36&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3/22&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.09&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;114.4&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;133&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Red&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Turbid&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Positive&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;56,000&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1196&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;46&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;54&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C albidus&lt;/italic&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3/30&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.22&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;129.1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;59&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Colorless&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Slightly turbid&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Slightly positive&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;104&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;25&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;75&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4/03&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.07&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;130.2&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;50&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Colorless&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Clear&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Positive&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;149&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;99&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Negative&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4/19&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.99&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;127.6&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;46&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Colorless&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Clear&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Negative&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1000&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;136&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;98&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Negative&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4/21&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.05&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;132.1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;28&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Colorless&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Clear&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Negative&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;26&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;96&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Negative&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>7319</offset><text>Hospitalization days	Glucose	Chloride	Microalbumin	Color	Turbidity	Pandy test	Red blood cells	White blood cells	Neutrophil	Lymphocyte	Culture	 	mmol/L	mmol/L	mg/L	/mm3	/mm3	%	%	 	3/16	2.88	118.2	80	Colorless	Clear	Positive	0	106	22	78		 	3/21	2.32	123	95	Colorless	Slightly turbid	Positive	1000	339	64	36		 	3/22	2.09	114.4	133	Red	Turbid	Positive	56,000	1196	46	54	C albidus	 	3/30	2.22	129.1	59	Colorless	Slightly turbid	Slightly positive	0	104	25	75		 	4/03	4.07	130.2	50	Colorless	Clear	Positive	0	149	1	99	Negative	 	4/19	3.99	127.6	46	Colorless	Clear	Negative	1000	136	2	98	Negative	 	4/21	4.05	132.1	28	Colorless	Clear	Negative	0	26	4	96	Negative	 	</text></passage><passage><infon key="file">medi-104-e42125-g002.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>7976</offset><text>MRI scan of the patient after surgery. The lesion in the right parietal lobe was resected, whereas the lesion in the left frontal lobe (red arrow) was still observed with long signals on T1-weighted (A) and T2-weighted (B) images. Enhanced MRI scanning showed that the lesion was only mildly enhanced after treatment (C).</text></passage><passage><infon key="file">medi-104-e42125-g003.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>8298</offset><text>Renal function of the patient. Adjusted creatinine clearance rate (Ccr) was calculated with the following equation: Ccr (mL/min) = (146 - age) × (0.287 × weight [kg] + 9.74 × height2 [m]2)/ (60 × serum creatinine[mg/dL]). BUN = blood urea nitrogen, Scr = serum creatinine.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>8603</offset><text>3. Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>8617</offset><text>C albidus in the genus Cryptococcus, is a rare species that causes cryptococcal infections, especially in the CNS infections. The antifungal treatment recommended for cryptococcal meningoencephalitis is liposomal-AmB plus flucytosine. Although liposomal-AmB has been used for several decades, little is known about its pharmacokinetics in obese patients. The prescribing information for cryptococcal disease recommends weight-based doses of 0.7 to 6 mg/kg/day AmB, depending upon the AmB product used. To date, the calculation of the appropriate dose for severely obese patients is controversial. Animal studies have demonstrated significantly increased AmB serum concentrations and increased rates of nephrotoxicity in obese rats and rabbits, with poor distribution of adipose tissue. Furthermore, women have a higher body fat rate than men, which is a risk factor for acute kidney injury caused by liposomal-AmB. Therefore, it may be reasonable to consider the ideal bodyweight rather than the actual bodyweight when calculating the dose of liposomal-AmB for severely obese female patients. In this case, we have demonstrated the efficacy and safety of using the ideal bodyweight, rather than the actual bodyweight, to calculate the dose of liposomal-AmB for a severely obese patient with C albidus meningitis.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9932</offset><text>A comprehensive review of the literature was performed in accordance with the “Preferred Reporting Items for Systematic Reviews and Meta-Analysis.” Studies of case report relevant to CNS infections attributed to C albidus and its related species in the PubMed, Medline, and Web of Science databases from their inception until July 2024. The following key words were used: fungus, human infection, CNS, meningitis, ventriculitis, encephalitis, non-neoformans, cryptococcus, naganishia, adeliensis, albida, albidus, chernovii, curvatus, diffluens, friedmannii, liquefaciens, magnus, terreus, uniguttulatus, and uzbekitanensis. The references in each manuscript were also reviewed to identify additional cases.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10644</offset><text>Our searches yielded 104 potentially relevant records. After nonhuman species (e.g., dog, cat, pigeon) were excluded, 86 studies were included. After non-CNS cases, non-research studies, non-Cryptococcus, C neoformans species complex, and C gattii species complex infections were excluded, 17 studies were reported. Of those 17 studies, 7 were cohort studies of Cryptococcus, and 1 study was of C laurentii meningitis combined with C albidus cryptococcaemia. Finally, 9 cases of CNS infections caused by C albidus or its related species have been reported. The risk factors, manifestations, diagnosis, and treatment for these pathogens are presented in table 2. Like other Cryptococcus species, C albidus and its related species were commonly isolated from the gastrointestinal tracts and droppings of birds. There is, as yet, no explanation of how humans contract these infections. Reasons may include the worldwide increase in immunocompromised patients, the widespread use of immunosuppressive agents, and the prolonged use of central venous catheters or indwelling devices. In our systematic review of the literature, we detected 2 cases of infection in human immunodeficiency virus (HIV) infected adults and 4 in apparently immunodeficient individuals. Leukemia and cancer are important risk factors in HIV-negative patients. The administration of corticosteroids agents, exposure to bird excrement, contact with animals, and surgery are also risk factors for these infections.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>12127</offset><text>Summary of data from central nervous system infection caused by C albidus and its related species in humans.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Author, year&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Country&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age/gender&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Potential risk factors&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Manifestation&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Duration of symptoms&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;italic toggle=&quot;yes&quot;&gt;Cryptococcus&lt;/italic&gt; species&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Taxonomical identification methods&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Treatment&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Outcomes&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;da Cunha Lusins (1973)&lt;sup&gt;&lt;xref rid=&quot;R2&quot; ref-type=&quot;bibr&quot;&gt;2&lt;/xref&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;New York, USA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;45/M&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Exposure to pigeon excrement&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Meningitis, headache, nausea and vomiting&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 days&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C albidus&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Culture&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AmB (1500 mg)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cured&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Melo et al (1980)&lt;sup&gt;&lt;xref rid=&quot;R3&quot; ref-type=&quot;bibr&quot;&gt;3&lt;/xref&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Kentucky&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;29/M&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Mentally retarded, receiving corticosteroids agents, surgery&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Meningitis, headache&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 weeks&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C albidus&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Culture&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AmB&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Died&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;McCurdy et al (2001)&lt;sup&gt;&lt;xref rid=&quot;R36&quot; ref-type=&quot;bibr&quot;&gt;36&lt;/xref&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Nashville, USA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;65/F&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ovarian cancer, invasive neurosurgical procedure&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ventriculitis, headache and mental status changes.&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 day&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C uniguttulatus&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Culture and ID 20C&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AmB (0.6 mg/kg) + 5-FU&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cured&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rimek et al (2004)&lt;sup&gt;&lt;xref rid=&quot;R37&quot; ref-type=&quot;bibr&quot;&gt;37&lt;/xref&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Germany&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;40/F&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Acute myeloid leukemia, peripheral blood stem cell transplantation and central venous catheter&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Meningitis, fever, headache and paraparesis&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 days&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C adeliensis&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Culture, ID 32C and ITS D1/D2 Sequencing&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Liposomal-AmB (5 mg/kg) + AmB (0.25 mg intrathecally biw) + 5-FU (120 mg/kg)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Died&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pan et al (2011)&lt;sup&gt;&lt;xref rid=&quot;R9&quot; ref-type=&quot;bibr&quot;&gt;9&lt;/xref&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;China&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;37/M&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Low CD4 lymphocyte count&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Meningitis, fever, cough, vomiting and headache&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15 days&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C uniguttulatus&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Culture and ITS D1/D2 Sequencing&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AmB (0.7 mg/kg) + 5-FU (100 mg/kg qid)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cured&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Liu et al (2013)&lt;sup&gt;&lt;xref rid=&quot;R7&quot; ref-type=&quot;bibr&quot;&gt;7&lt;/xref&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;China&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;28/M&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AIDS&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Encephalitis, diplopia, vomiting, tinnitus, neck stiffness, strabism and vertigo.&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 weeks&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C albidus&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Culture&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fluconazole (NA)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Died&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Conde-Pereira et al (2015)&lt;sup&gt;&lt;xref rid=&quot;R38&quot; ref-type=&quot;bibr&quot;&gt;38&lt;/xref&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Guatemala&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;31/F&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AIDS&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Meningitis, headache, vomiting, fever, asthenia and adynamia&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 month&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C liquefaciens&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Culture, ID 32C, MALDI-TOF MS and ITS D1/D2 Sequencing&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AmB deoxycholate (0.7 mg/kg)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Died&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Animalu et al (2015)&lt;sup&gt;&lt;xref rid=&quot;R39&quot; ref-type=&quot;bibr&quot;&gt;39&lt;/xref&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Memphis, USA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;72/F&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-small-cell lung carcinoma&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Meningitis, headache, nausea and emesis&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;unknown&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C uniguttulatus&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Culture and ID 20C&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Liposomal-AmB (5 mg/kg) + fluconazole (400 mg bid)→ voriconazole&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cured&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Present case&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;China&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;25/F&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Glioma, surgery&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Meningitis, headache, vomiting and nausea&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 months&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C albidus&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Culture and VITEK MS&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Liposomal Amp B (50 mg qd) + 5-FU (100 mg/kg qid)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cured&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>12236</offset><text>Author, year	Country	Age/gender	Potential risk factors	Manifestation	Duration of symptoms	Cryptococcus species	Taxonomical identification methods	Treatment	Outcomes	 	da Cunha Lusins (1973)	New York, USA	45/M	Exposure to pigeon excrement	Meningitis, headache, nausea and vomiting	3 days	C albidus	Culture	AmB (1500 mg)	Cured	 	Melo et al (1980)	Kentucky	29/M	Mentally retarded, receiving corticosteroids agents, surgery	Meningitis, headache	2 weeks	C albidus	Culture	AmB	Died	 	McCurdy et al (2001)	Nashville, USA	65/F	Ovarian cancer, invasive neurosurgical procedure	Ventriculitis, headache and mental status changes.	1 day	C uniguttulatus	Culture and ID 20C	AmB (0.6 mg/kg) + 5-FU	Cured	 	Rimek et al (2004)	Germany	40/F	Acute myeloid leukemia, peripheral blood stem cell transplantation and central venous catheter	Meningitis, fever, headache and paraparesis	4 days	C adeliensis	Culture, ID 32C and ITS D1/D2 Sequencing	Liposomal-AmB (5 mg/kg) + AmB (0.25 mg intrathecally biw) + 5-FU (120 mg/kg)	Died	 	Pan et al (2011)	China	37/M	Low CD4 lymphocyte count	Meningitis, fever, cough, vomiting and headache	15 days	C uniguttulatus	Culture and ITS D1/D2 Sequencing	AmB (0.7 mg/kg) + 5-FU (100 mg/kg qid)	Cured	 	Liu et al (2013)	China	28/M	AIDS	Encephalitis, diplopia, vomiting, tinnitus, neck stiffness, strabism and vertigo.	2 weeks	C albidus	Culture	Fluconazole (NA)	Died	 	Conde-Pereira et al (2015)	Guatemala	31/F	AIDS	Meningitis, headache, vomiting, fever, asthenia and adynamia	1 month	C liquefaciens	Culture, ID 32C, MALDI-TOF MS and ITS D1/D2 Sequencing	AmB deoxycholate (0.7 mg/kg)	Died	 	Animalu et al (2015)	Memphis, USA	72/F	Non-small-cell lung carcinoma	Meningitis, headache, nausea and emesis	unknown	C uniguttulatus	Culture and ID 20C	Liposomal-AmB (5 mg/kg) + fluconazole (400 mg bid)→ voriconazole	Cured	 	Present case	China	25/F	Glioma, surgery	Meningitis, headache, vomiting and nausea	6 months	C albidus	Culture and VITEK MS	Liposomal Amp B (50 mg qd) + 5-FU (100 mg/kg qid)	Cured	 	</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>14291</offset><text>→ = change to, AIDS = acquired immunodeficiency syndrome, AmB = amphotericin B, F = female, 5-FU = fluconazole, ITS = internal transcribed space, M = male, MALDI-TOF MS = matrix-assisted laser desorption ionization-time of flight mass spectrometry, MS = mass spectrometry.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>14578</offset><text>Patients can present with headache, fever, altered mental state, nausea, and vomiting. Headache is the commonest symptom, and only 1 patient reported no headache. Although fever is possible, it only presented in 3 cases (31%). These results are similar to a cohort study that showed fever present in 28% of cases. Patients also presented with increased intracranial pressure increasing and altered mental states, and these neurological symptoms are similar to other cryptococcal infections. The cryptococcal capsule lodges in the arachnoid villi and subsequently prevents CSF reabsorption may explain the elevated intracranial pressure.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15215</offset><text>Culture and API® strip assimilation test are laboratory commonly used methods to identify isolated Cryptococcus species. However, it may be difficult to identify species when only 1 or 2 methods are used. Without the sequence of the D1/D2 domains of the large-subunit of ribosomal RNA (rRNA), some rare Cryptococcus species can be misidentified as C albidus. For example, a yeast isolate was initially identified as C albidus with an API® strip assimilation test. However, after the internal transcribed spacer and the D1/D2 domains of the large-subunit rRNA were sequenced, the isolate was finally confirmed as C liquefaciens. Mass spectrometry is a new methodology for identifying bacterial species, and some studies have shown that the accuracy of mass spectrometry for their identification is over 95% at the species level. Hence, the identification of C albidus based on VITEK mass spectrometry is reliable.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>16130</offset><text>Because these fungi are infrequent causes of disease, there are no evidence-based guidelines or standard recommendations for their treatment. The susceptibility of C albidus and its related species to antifungal agents is shown in Table 3. The cumulative experience reported in the published literature suggests that AmB is the only agent to which C albidus and its related species are consistently sensitive. Therefore, AmB is a safe and effective drug for use as initial induction therapy against these infections in the CNS. However, consideration should be given henceforth to submitting these clinical isolates for susceptibility testing and proper identification to guide subsequent therapeutic decisions. To date, no randomized controlled trials have been conducted to optimize the choice of AmB or the duration of its therapy. We recommend: (1) using liposomal-AmB instead of AmB deoxycholate because liposomal-AmB is safer and more rapidly sterilizes the CSF than AmB deoxycholate; (2) at least 1 g of AmB during treatment and prolonged treatment are recommended. (3) The combination of AmB and 5-fluorocytosine, is recommended because it has been shown to reduce the toxicity of this drug and reduce the relapse rate of C albidus infections.</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>17384</offset><text>Antifungal susceptibility of Cryptococcus species.</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;3&quot; colspan=&quot;1&quot;&gt;Antifungal agents&lt;/th&gt;&lt;th align=&quot;center&quot; colspan=&quot;6&quot; rowspan=&quot;1&quot;&gt;Minimal inhibitory concentrations (μg/mL)&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;McCurdy et al (2001)&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rimek et al (2004)&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pan et al (2011)&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Conde-Pereira et al (2015)&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Animalu et al (2015)&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Present case&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C uniguttulatus&lt;/italic&gt;
&lt;sup&gt;&lt;xref rid=&quot;R36&quot; ref-type=&quot;bibr&quot;&gt;36&lt;/xref&gt;&lt;/sup&gt;
&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C adeliensis&lt;/italic&gt;
&lt;sup&gt;&lt;xref rid=&quot;R37&quot; ref-type=&quot;bibr&quot;&gt;37&lt;/xref&gt;&lt;/sup&gt;
&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C uniguttulatum&lt;/italic&gt;
&lt;sup&gt;&lt;xref rid=&quot;R9&quot; ref-type=&quot;bibr&quot;&gt;9&lt;/xref&gt;&lt;/sup&gt;
&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C liquefaciens&lt;/italic&gt;
&lt;sup&gt;&lt;xref rid=&quot;R38&quot; ref-type=&quot;bibr&quot;&gt;38&lt;/xref&gt;&lt;/sup&gt;
&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C uniguttulatus&lt;/italic&gt;
&lt;sup&gt;&lt;xref rid=&quot;R39&quot; ref-type=&quot;bibr&quot;&gt;39&lt;/xref&gt;&lt;/sup&gt;
&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic toggle=&quot;yes&quot;&gt;C albidus&lt;/italic&gt;
&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Amphotericin B&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.25&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.125&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.125&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;≤0.12&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5-Flucytosine&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;64&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;64&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;64&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;64&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;64&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fluconazole&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;64&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;32&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;64&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;256&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;128&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Voriconazole&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NG&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.25&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.5&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;8&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.25&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Itraconazole&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.25&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;16&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.5&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.125&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Posaconazole&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NG&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NG&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.5&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;8&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NG&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>17435</offset><text>Antifungal agents	Minimal inhibitory concentrations (μg/mL)	 	McCurdy et al (2001)	Rimek et al (2004)	Pan et al (2011)	Conde-Pereira et al (2015)	Animalu et al (2015)	Present case	 	C uniguttulatus	C adeliensis	C uniguttulatum	C liquefaciens	C uniguttulatus	C albidus	 	Amphotericin B	0.25	0.125	0.125	1	≤0.12	0.5	 	5-Flucytosine	&gt;64	&gt;64	&gt;64	&gt;64	64	4	 	Fluconazole	&gt;64	32	64	&gt;256	128	4	 	Voriconazole	NG	0.25	0.5	&gt;8	0.25	1	 	Itraconazole	1	0.25	1	&gt;16	0.5	0.125	 	Posaconazole	NG	NG	0.5	&gt;8	1	NG	 	</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>17935</offset><text>4. Conclusion</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>17949</offset><text>Using the ideal bodyweight to calculate the appropriate dose of liposomal-AmB for obese patients with C albidus meningitis is both efficacious and safe. Based on the systematic review of CNS infections of C albidus and its related species, we also concluded that leukemia and cancer are important risk factors for these infections and that headache is the most frequent symptom. The identification of fungal pathogens requires the analysis the rRNA sequences because many species share phenotypic similarities. AmB-based treatment should be the first choice, and subsequent treatment should be guided by susceptibility testing.</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">title_1</infon><offset>18577</offset><text>Acknowledgments</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">paragraph</infon><offset>18593</offset><text>We thank the patient for participating in this study. We thank International Science Editing (http://www.internationalscienceediting.com) for editing this manuscript. We thank Professor Yiyou Gu (The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA) for review services and Professor Xiaorui Wang (Beijing Electric Power Hospital) for critical reading of the MRI scan results.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title_1</infon><offset>18998</offset><text>Author contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>19019</offset><text>Conceptualization: Zhongdong Li.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>19052</offset><text>Data curation: Hang Liu, Xiaoying Wang.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>19092</offset><text>Methodology: Hang Liu.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>19115</offset><text>Writing – original draft: Genzhu Wang.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>19156</offset><text>Writing – review &amp; editing: Xiaoying Wang, Zhongdong Li.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote_title</infon><offset>19215</offset><text>Abbreviations:</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19230</offset><text>AmB</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19234</offset><text>amphotericin B</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19249</offset><text>C albidus</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19259</offset><text>Cryptococcus albidus</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19280</offset><text>CNS</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19284</offset><text>central nervous system</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19307</offset><text>CSF</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19311</offset><text>cerebrospinal fluid,</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19332</offset><text>rRNA</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19337</offset><text>ribosomal RNA</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19351</offset><text>The authors declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Beijing Electric Power Hospital Doctoral Fund Project (No. B2022001) and the Beijing Natural Science Foundation (grant number: 7234407).</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19637</offset><text>Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin. Written informed consent was obtained from the individual for the publication of any potentially identifiable images or data included in this article.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>19910</offset><text>This study was approved by the ethics committee of Beijing Electric Power Hospital, State Grid Corporation of China (Ethics Number: KY-2021-018-01). The studies were conducted in accordance with the local legislation and institutional requirements.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>20159</offset><text>The authors have no conflicts of interest to disclose.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>20214</offset><text>The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>20352</offset><text>How to cite this article: Wang G, Liu H, Wang X, Li Z. Cryptococcus albidus meningitis: A case report and literature review. Medicine 2025;104:17(e42125).</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">footnote</infon><offset>20507</offset><text>GW and HL contributed equally to this work.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>20551</offset><text>References</text></passage><passage><infon key="fpage">475</infon><infon key="lpage">81</infon><infon key="name_0">surname:Wieser;given-names:HG</infon><infon key="pub-id_pmid">4572957</infon><infon key="section_type">REF</infon><infon key="source">Schweiz Med Wochenschr</infon><infon key="type">ref</infon><infon key="volume">103</infon><infon key="year">1973</infon><offset>20562</offset><text>Pathogenicity of Crytococcus albidus.</text></passage><passage><infon key="fpage">1230 passim</infon><infon key="name_0">surname:Da Cunha;given-names:T</infon><infon key="name_1">surname:Lusins;given-names:J</infon><infon key="pub-id_pmid">4745601</infon><infon key="section_type">REF</infon><infon key="source">South Med J</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">1973</infon><offset>20600</offset><text>Cryptococcus albidus meningitis.</text></passage><passage><infon key="fpage">79</infon><infon key="lpage">82</infon><infon key="name_0">surname:Melo;given-names:JC</infon><infon key="name_1">surname:Srinivasan;given-names:S</infon><infon key="name_2">surname:Scott;given-names:ML</infon><infon key="name_3">surname:Raff;given-names:MJ</infon><infon key="pub-id_pmid">7185917</infon><infon key="section_type">REF</infon><infon key="source">J Infect</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">1980</infon><offset>20633</offset><text>Cryptococcus albidus meningitis.</text></passage><passage><infon key="fpage">511</infon><infon key="lpage">3</infon><infon key="name_0">surname:Gluck;given-names:JL</infon><infon key="name_1">surname:Myers;given-names:JP</infon><infon key="name_2">surname:Pass;given-names:LM</infon><infon key="pub-id_pmid">3470948</infon><infon key="section_type">REF</infon><infon key="source">South Med J</infon><infon key="type">ref</infon><infon key="volume">80</infon><infon key="year">1987</infon><offset>20666</offset><text>Cryptococcemia due to Cryptococcus albidus.</text></passage><passage><infon key="fpage">51</infon><infon key="lpage">8</infon><infon key="name_0">surname:Khawcharoenporn;given-names:T</infon><infon key="name_1">surname:Apisarnthanarak;given-names:A</infon><infon key="name_2">surname:Mundy;given-names:LM</infon><infon key="pub-id_pmid">17401707</infon><infon key="section_type">REF</infon><infon key="source">Infection</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">2007</infon><offset>20710</offset><text>Non-neoformans cryptococcal infections: a systematic review.</text></passage><passage><infon key="fpage">100</infon><infon key="lpage">5</infon><infon key="name_0">surname:Choe;given-names:YJ</infon><infon key="name_1">surname:Blatt;given-names:DB</infon><infon key="name_2">surname:Yalcindag;given-names:A</infon><infon key="name_3">surname:Geffert;given-names:SF</infon><infon key="name_4">surname:Bobenchik;given-names:AM</infon><infon key="name_5">surname:Michelow;given-names:IC</infon><infon key="pub-id_pmid">31183496</infon><infon key="section_type">REF</infon><infon key="source">J. Pediatric Infect. Dis. Soc</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2020</infon><offset>20771</offset><text>Cryptococcus albidus fungemia in an immunosuppressed child: case report and systematic literature review.</text></passage><passage><infon key="fpage">8</infon><infon key="lpage">10</infon><infon key="name_0">surname:Liu;given-names:Y</infon><infon key="name_1">surname:Ma;given-names:S</infon><infon key="name_2">surname:Wang;given-names:X</infon><infon key="name_3">surname:Xu;given-names:W</infon><infon key="name_4">surname:Tang;given-names:J</infon><infon key="pub-id_pmid">24567892</infon><infon key="section_type">REF</infon><infon key="source">Med Mycol Case Rep</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2014</infon><offset>20877</offset><text>Cryptococcus albidus encephalitis in newly diagnosed HIV-patient and literature review.</text></passage><passage><infon key="fpage">7</infon><infon key="lpage">27</infon><infon key="name_0">surname:Fonseca;given-names:A</infon><infon key="name_1">surname:Scorzetti;given-names:G</infon><infon key="name_2">surname:Fell;given-names:JW</infon><infon key="pub-id_pmid">10696468</infon><infon key="section_type">REF</infon><infon key="source">Can J Microbiol</infon><infon key="type">ref</infon><infon key="volume">46</infon><infon key="year">2000</infon><offset>20965</offset><text>Diversity in the yeast Cryptococcus albidus and related species as revealed by ribosomal DNA sequence analysis.</text></passage><passage><infon key="fpage">105</infon><infon key="lpage">9</infon><infon key="name_0">surname:Pan;given-names:W</infon><infon key="name_1">surname:Liao;given-names:W</infon><infon key="name_2">surname:Hagen;given-names:F</infon><infon key="pub-id_pmid">21729175</infon><infon key="section_type">REF</infon><infon key="source">Mycoses</infon><infon key="type">ref</infon><infon key="volume">55</infon><infon key="year">2012</infon><offset>21077</offset><text>Meningitis caused by Filobasidium uniguttulatum: case report and overview of the literature.</text></passage><passage><infon key="fpage">291</infon><infon key="lpage">322</infon><infon key="name_0">surname:Perfect;given-names:JR</infon><infon key="name_1">surname:Dismukes;given-names:WE</infon><infon key="name_2">surname:Dromer;given-names:F</infon><infon key="pub-id_pmid">20047480</infon><infon key="section_type">REF</infon><infon key="source">Clin Infect Dis</infon><infon key="type">ref</infon><infon key="volume">50</infon><infon key="year">2010</infon><offset>21170</offset><text>Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.</text></passage><passage><infon key="fpage">1109</infon><infon key="lpage">20</infon><infon key="name_0">surname:Jarvis;given-names:JN</infon><infon key="name_1">surname:Lawrence;given-names:DS</infon><infon key="name_2">surname:Meya;given-names:DB</infon><infon key="pub-id_pmid">35320642</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">386</infon><infon key="year">2022</infon><offset>21302</offset><text>Single-dose liposomal amphotericin B treatment for cryptococcal meningitis.</text></passage><passage><infon key="fpage">485</infon><infon key="lpage">500</infon><infon key="name_0">surname:Stone;given-names:NR</infon><infon key="name_1">surname:Bicanic;given-names:T</infon><infon key="name_2">surname:Salim;given-names:R</infon><infon key="name_3">surname:Hope;given-names:W</infon><infon key="pub-id_pmid">26818726</infon><infon key="section_type">REF</infon><infon key="source">Drugs</infon><infon key="type">ref</infon><infon key="volume">76</infon><infon key="year">2016</infon><offset>21378</offset><text>Liposomal Amphotericin B (AmBisome(®)): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions.</text></passage><passage><infon key="fpage">2213</infon><infon key="lpage">5</infon><infon key="name_0">surname:Wasmann;given-names:RE</infon><infon key="name_1">surname:Smit;given-names:C</infon><infon key="name_2">surname:Van Dongen;given-names:EPH</infon><infon key="pub-id_pmid">31588493</infon><infon key="section_type">REF</infon><infon key="source">Clin Infect Dis</infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">2020</infon><offset>21514</offset><text>Fixed dosing of liposomal amphotericin B in morbidly obese individuals.</text></passage><passage><infon key="fpage">e0236620</infon><infon key="name_0">surname:Ting;given-names:MH</infon><infon key="name_1">surname:Spec;given-names:A</infon><infon key="name_2">surname:Micek;given-names:ST</infon><infon key="name_3">surname:Ritchie;given-names:DJ</infon><infon key="name_4">surname:Krekel;given-names:T</infon><infon key="pub-id_pmid">34125591</infon><infon key="section_type">REF</infon><infon key="source">Antimicrob Agents Chemother</infon><infon key="type">ref</infon><infon key="volume">65</infon><infon key="year">2021</infon><offset>21586</offset><text>Evaluation of total body weight versus adjusted body weight liposomal amphotericin B dosing in obese patients.</text></passage><passage><infon key="fpage">584</infon><infon key="lpage">608</infon><infon key="name_0">surname:Polso;given-names:AK</infon><infon key="name_1">surname:Lassiter;given-names:JL</infon><infon key="name_2">surname:Nagel;given-names:JL</infon><infon key="pub-id_pmid">25203631</infon><infon key="section_type">REF</infon><infon key="source">J Clin Pharm Ther</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2014</infon><offset>21697</offset><text>Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.</text></passage><passage><infon key="fpage">416</infon><infon key="name_0">surname:Yongwu;given-names:C</infon><infon key="name_1">surname:Shengyu;given-names:Z</infon><infon key="name_2">surname:Xiaowen;given-names:H</infon><infon key="section_type">REF</infon><infon key="source">Herald Med</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">2021</infon><offset>21826</offset><text>Risk factors analysis of liposomal amphotericin B-related acute kidney injury.</text></passage><passage><infon key="fpage">e28218</infon><infon key="name_0">surname:Wang;given-names:G</infon><infon key="name_1">surname:Zhang;given-names:Y</infon><infon key="name_2">surname:Wang;given-names:X</infon><infon key="pub-id_pmid">34941082</infon><infon key="section_type">REF</infon><infon key="source">Medicine (Baltimore)</infon><infon key="type">ref</infon><infon key="volume">100</infon><infon key="year">2021</infon><offset>21905</offset><text>Long-acting versus short-acting granulocyte colony-stimulating factors among cancer patients after chemotherapy in China: a systematic review and meta-analysis of randomized controlled trials.</text></passage><passage><infon key="fpage">e25487</infon><infon key="name_0">surname:Wang;given-names:G</infon><infon key="name_1">surname:Lin;given-names:Z</infon><infon key="name_2">surname:Wang;given-names:X</infon><infon key="pub-id_pmid">33907097</infon><infon key="section_type">REF</infon><infon key="source">Medicine (Baltimore)</infon><infon key="type">ref</infon><infon key="volume">100</infon><infon key="year">2021</infon><offset>22098</offset><text>The association between 5, 10 - methylenetetrahydrofolate reductase and the risk of unexplained recurrent pregnancy loss in China: a meta-analysis.</text></passage><passage><infon key="fpage">1</infon><infon key="name_0">surname:Moher;given-names:D</infon><infon key="name_1">surname:Shamseer;given-names:L</infon><infon key="name_2">surname:Clarke;given-names:M</infon><infon key="pub-id_pmid">25554246</infon><infon key="section_type">REF</infon><infon key="source">Syst Rev</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2015</infon><offset>22246</offset><text>Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.</text></passage><passage><infon key="fpage">75</infon><infon key="lpage">7</infon><infon key="name_0">surname:Kano;given-names:R</infon><infon key="name_1">surname:Kitagawat;given-names:M</infon><infon key="name_2">surname:Oota;given-names:S</infon><infon key="pub-id_pmid">17885946</infon><infon key="section_type">REF</infon><infon key="source">Med Mycol</infon><infon key="type">ref</infon><infon key="volume">46</infon><infon key="year">2008</infon><offset>22349</offset><text>First case of feline systemic Cryptococcus albidus infection.</text></passage><passage><infon key="fpage">1000</infon><infon key="lpage">4</infon><infon key="name_0">surname:Poth;given-names:T</infon><infon key="name_1">surname:Seibold;given-names:M</infon><infon key="name_2">surname:Werckenthin;given-names:C</infon><infon key="name_3">surname:Hermanns;given-names:W</infon><infon key="pub-id_pmid">20513171</infon><infon key="section_type">REF</infon><infon key="source">Med Mycol</infon><infon key="type">ref</infon><infon key="volume">48</infon><infon key="year">2010</infon><offset>22411</offset><text>First report of a Cryptococcus magnus infection in a cat.</text></passage><passage><infon key="fpage">421</infon><infon key="lpage">4</infon><infon key="name_0">surname:Krumholz;given-names:RA</infon><infon key="pub-id_pmid">5011671</infon><infon key="section_type">REF</infon><infon key="source">Am Rev Respir Dis</infon><infon key="type">ref</infon><infon key="volume">105</infon><infon key="year">1972</infon><offset>22469</offset><text>Pulmonary cryptococcosis. A case due to Cryptococcus albidus.</text></passage><passage><infon key="fpage">544</infon><infon key="lpage">6</infon><infon key="name_0">surname:Wells;given-names:GM</infon><infon key="name_1">surname:Gajjar;given-names:A</infon><infon key="name_2">surname:Pearson;given-names:TA</infon><infon key="name_3">surname:Hale;given-names:KL</infon><infon key="name_4">surname:Shenep;given-names:JL</infon><infon key="pub-id_pmid">9835915</infon><infon key="section_type">REF</infon><infon key="source">Med Pediatr Oncol</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">1998</infon><offset>22531</offset><text>Brief report. Pulmonary cryptosporidiosis and Cryptococcus albidus fungemia in a child with acute lymphocytic leukemia.</text></passage><passage><infon key="fpage">e34</infon><infon key="name_0">surname:Rodriguez-Leguizamon;given-names:G</infon><infon key="name_1">surname:Coque-Burgos;given-names:E</infon><infon key="name_2">surname:Espitia-Castro;given-names:O</infon><infon key="name_3">surname:Firacative;given-names:C</infon><infon key="pub-id_pmid">32491141</infon><infon key="section_type">REF</infon><infon key="source">Rev Inst Med Trop Sao Paulo</infon><infon key="type">ref</infon><infon key="volume">62</infon><infon key="year">2020</infon><offset>22651</offset><text>Fatal fungaemia due to Cryptococcus albidus in an elderly diabetic woman presenting with pleural effusion.</text></passage><passage><infon key="fpage">e60</infon><infon key="name_0">surname:Oliveira;given-names:VF</infon><infon key="name_1">surname:Funari;given-names:AP</infon><infon key="name_2">surname:Taborda;given-names:M</infon><infon key="name_3">surname:Magri;given-names:ASGK</infon><infon key="name_4">surname:Levin;given-names:AS</infon><infon key="name_5">surname:Magri;given-names:MMC</infon><infon key="pub-id_pmid">38055378</infon><infon key="section_type">REF</infon><infon key="source">Rev Inst Med Trop Sao Paulo</infon><infon key="type">ref</infon><infon key="volume">65</infon><infon key="year">2023</infon><offset>22758</offset><text>Cutaneous Naganishia albida (Cryptococcus albidus) infection: a case report and literature review.</text></passage><passage><infon key="fpage">e34</infon><infon key="lpage">65</infon><infon key="name_0">surname:Tunkel;given-names:AR</infon><infon key="name_1">surname:Hasbun;given-names:R</infon><infon key="name_2">surname:Bhimraj;given-names:A</infon><infon key="pub-id_pmid">28203777</infon><infon key="section_type">REF</infon><infon key="source">Clin Infect Dis</infon><infon key="type">ref</infon><infon key="volume">64</infon><infon key="year">2017</infon><offset>22857</offset><text>2017 Infectious diseases society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis.</text></passage><passage><infon key="fpage">279</infon><infon key="name_0">surname:Morales-Lopez;given-names:SE</infon><infon key="name_1">surname:Garcia-Effron;given-names:G</infon><infon key="pub-id_pmid">33917243</infon><infon key="section_type">REF</infon><infon key="source">J Fungi (Basel)</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2021</infon><offset>22990</offset><text>Infections due to rare cryptococcus species. A literature review.</text></passage><passage><infon key="fpage">100</infon><infon key="lpage">3</infon><infon key="name_0">surname:Dorneanu;given-names:O</infon><infon key="name_1">surname:Filip;given-names:O</infon><infon key="name_2">surname:Miftode;given-names:E</infon><infon key="pub-id_pmid">18677910</infon><infon key="section_type">REF</infon><infon key="source">Rev Med Chir Soc Med Nat Iasi</infon><infon key="type">ref</infon><infon key="volume">112</infon><infon key="year">2008</infon><offset>23056</offset><text>Cryptococcus meningitis, five years of experience and literature review.</text></passage><passage><infon key="fpage">252</infon><infon key="lpage">61</infon><infon key="name_0">surname:Marr;given-names:KA</infon><infon key="name_1">surname:Sun;given-names:Y</infon><infon key="name_2">surname:Spec;given-names:A</infon><infon key="pub-id_pmid">30855688</infon><infon key="section_type">REF</infon><infon key="source">Clin Infect Dis</infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">2020</infon><offset>23129</offset><text>A multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency virus-negative people in the United States.</text></passage><passage><infon key="fpage">368</infon><infon key="lpage">73</infon><infon key="name_0">surname:Utz;given-names:JP</infon><infon key="name_1">surname:Garriques;given-names:IL</infon><infon key="name_2">surname:Sande;given-names:MA</infon><infon key="pub-id_pmid">1185007</infon><infon key="section_type">REF</infon><infon key="source">J Infect Dis</infon><infon key="type">ref</infon><infon key="volume">132</infon><infon key="year">1975</infon><offset>23258</offset><text>Therapy of cryptococcosis with a combination of flucytosine and amphotericin B.</text></passage><passage><infon key="fpage">126</infon><infon key="lpage">31</infon><infon key="name_0">surname:Bennett;given-names:JE</infon><infon key="name_1">surname:Dismukes;given-names:WE</infon><infon key="name_2">surname:Duma;given-names:RJ</infon><infon key="pub-id_pmid">449951</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">301</infon><infon key="year">1979</infon><offset>23338</offset><text>A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.</text></passage><passage><infon key="fpage">57</infon><infon key="issue">Suppl 1</infon><infon key="lpage">61</infon><infon key="name_0">surname:Chen;given-names:SC</infon><infon key="pub-id_pmid">11801583</infon><infon key="section_type">REF</infon><infon key="source">J Antimicrob Chemother</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="year">2002</infon><offset>23448</offset><text>Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B.</text></passage><passage><infon key="fpage">225</infon><infon key="lpage">32</infon><infon key="name_0">surname:Hamill;given-names:RJ</infon><infon key="name_1">surname:Sobel;given-names:JD</infon><infon key="name_2">surname:El-Sadr;given-names:W</infon><infon key="pub-id_pmid">20536366</infon><infon key="section_type">REF</infon><infon key="source">Clin Infect Dis</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2010</infon><offset>23571</offset><text>Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety.</text></passage><passage><infon key="fpage">2522</infon><infon key="lpage">3</infon><infon key="name_0">surname:Day;given-names:JN</infon><infon key="name_1">surname:Chau;given-names:TT</infon><infon key="name_2">surname:Lalloo;given-names:DG</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">368</infon><infon key="year">2013</infon><offset>23796</offset><text>Combination antifungal therapy for cryptococcal meningitis.</text></passage><passage><infon key="fpage">335</infon><infon key="lpage">9</infon><infon key="name_0">surname:Kordossis;given-names:T</infon><infon key="name_1">surname:Avlami;given-names:A</infon><infon key="name_2">surname:Velegraki;given-names:A</infon><infon key="pub-id_pmid">10075504</infon><infon key="section_type">REF</infon><infon key="source">Med Mycol</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="year">1998</infon><offset>23856</offset><text>First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.</text></passage><passage><infon key="fpage">65</infon><infon key="lpage">6</infon><infon key="name_0">surname:Mccurdy;given-names:LH</infon><infon key="name_1">surname:Morrow;given-names:JD</infon><infon key="pub-id_pmid">11213945</infon><infon key="section_type">REF</infon><infon key="source">South Med J</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">2001</infon><offset>23981</offset><text>Ventriculitis due to Cryptococcus uniguttulatus.</text></passage><passage><infon key="fpage">481</infon><infon key="lpage">3</infon><infon key="name_0">surname:Rimek;given-names:D</infon><infon key="name_1">surname:Haase;given-names:G</infon><infon key="name_2">surname:Lück;given-names:A</infon><infon key="name_3">surname:Casper;given-names:J</infon><infon key="name_4">surname:Podbielski;given-names:A</infon><infon key="pub-id_pmid">14715811</infon><infon key="section_type">REF</infon><infon key="source">J Clin Microbiol</infon><infon key="type">ref</infon><infon key="volume">42</infon><infon key="year">2004</infon><offset>24030</offset><text>First report of a case of meningitis caused by Cryptococcus adeliensis in a patient with acute myeloid leukemia.</text></passage><passage><infon key="fpage">2753</infon><infon key="lpage">5</infon><infon key="name_0">surname:Conde-Pereira;given-names:C</infon><infon key="name_1">surname:Rodas-Rodríguez;given-names:L</infon><infon key="name_2">surname:Díaz-Paz;given-names:M</infon><infon key="pub-id_pmid">26019205</infon><infon key="section_type">REF</infon><infon key="source">J Clin Microbiol</infon><infon key="type">ref</infon><infon key="volume">53</infon><infon key="year">2015</infon><offset>24143</offset><text>Fatal case of polymicrobial meningitis caused by cryptococcus liquefaciens and mycobacterium tuberculosis complex in a human immunodeficiency virus-infected patient.</text></passage><passage><infon key="fpage">421</infon><infon key="lpage">2</infon><infon key="name_0">surname:Animalu;given-names:C</infon><infon key="name_1">surname:Mazumder;given-names:S</infon><infon key="name_2">surname:Cleveland;given-names:KO</infon><infon key="name_3">surname:Gelfand;given-names:MS</infon><infon key="pub-id_pmid">26371608</infon><infon key="section_type">REF</infon><infon key="source">Am J Med Sci</infon><infon key="type">ref</infon><infon key="volume">350</infon><infon key="year">2015</infon><offset>24309</offset><text>Cryptococcus uniguttulatus meningitis.</text></passage><passage><infon key="fpage">1033</infon><infon key="lpage">46</infon><infon key="name_0">surname:Nematollahi;given-names:S</infon><infon key="name_1">surname:Dioverti-Prono;given-names:V</infon><infon key="pub-id_pmid">32740974</infon><infon key="section_type">REF</infon><infon key="source">Mycoses</infon><infon key="type">ref</infon><infon key="volume">63</infon><infon key="year">2020</infon><offset>24348</offset><text>Cryptococcal infection in haematologic malignancies and haematopoietic stem cell transplantation.</text></passage><passage><infon key="fpage">291</infon><infon key="lpage">7</infon><infon key="name_0">surname:Sugita;given-names:T</infon><infon key="name_1">surname:Takashima;given-names:M</infon><infon key="name_2">surname:Ikeda;given-names:R</infon><infon key="name_3">surname:Nakase;given-names:T</infon><infon key="name_4">surname:Shinoda;given-names:T</infon><infon key="pub-id_pmid">11386419</infon><infon key="section_type">REF</infon><infon key="source">Microbiol Immunol</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2001</infon><offset>24446</offset><text>Intraspecies diversity of Cryptococcus albidus isolated from humans as revealed by sequences of the internal transcribed spacer regions.</text></passage><passage><infon key="fpage">110813</infon><infon key="name_0">surname:Heckler;given-names:C</infon><infon key="name_1">surname:Vale;given-names:MG</infon><infon key="name_2">surname:Canales;given-names:HDS</infon><infon key="pub-id_pmid">38970997</infon><infon key="section_type">REF</infon><infon key="source">Int J Food Microbiol</infon><infon key="type">ref</infon><infon key="volume">422</infon><infon key="year">2024</infon><offset>24583</offset><text>Spore-forming bacteria in gelatin: Characterization, identification by 16S rRNA and MALDI-TOF mass spectrometry (MS), and presence of heat resistance and virulence genes.</text></passage><passage><infon key="fpage">e0305167</infon><infon key="name_0">surname:Chaumeau;given-names:V</infon><infon key="name_1">surname:Piarroux;given-names:M</infon><infon key="name_2">surname:Kulabkeeree;given-names:T</infon><infon key="pub-id_pmid">38968228</infon><infon key="section_type">REF</infon><infon key="source">PLoS One</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2024</infon><offset>24754</offset><text>Identification of Southeast Asian Anopheles mosquito species using MALDI-TOF mass spectrometry.</text></passage><passage><infon key="fpage">289</infon><infon key="lpage">96</infon><infon key="name_0">surname:Eigner;given-names:U</infon><infon key="name_1">surname:Holfelder;given-names:M</infon><infon key="name_2">surname:Oberdorfer;given-names:K</infon><infon key="name_3">surname:Betz-Wild;given-names:U</infon><infon key="name_4">surname:Bertsch;given-names:D</infon><infon key="name_5">surname:Fahr;given-names:A-M</infon><infon key="pub-id_pmid">19894408</infon><infon key="section_type">REF</infon><infon key="source">Clin Lab</infon><infon key="type">ref</infon><infon key="volume">55</infon><infon key="year">2009</infon><offset>24850</offset><text>Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory.</text></passage><passage><infon key="fpage">421</infon><infon key="lpage">7</infon><infon key="name_0">surname:Ragupathi;given-names:L</infon><infon key="name_1">surname:Reyna;given-names:M</infon><infon key="pub-id_pmid">24584615</infon><infon key="section_type">REF</infon><infon key="source">Perit Dial Int</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">2015</infon><offset>25032</offset><text>Case report of Cryptococcus albidus peritonitis in a peritoneal dialysis patient and a review of the literature.</text></passage><passage><infon key="fpage">76</infon><infon key="issue">Suppl 3</infon><infon key="lpage">98</infon><infon key="name_0">surname:Arendrup;given-names:MC</infon><infon key="name_1">surname:Boekhout;given-names:T</infon><infon key="name_2">surname:Akova;given-names:M</infon><infon key="name_3">surname:Meis;given-names:JF</infon><infon key="name_4">surname:Cornely;given-names:OA</infon><infon key="name_5">surname:Lortholary;given-names:O</infon><infon key="section_type">REF</infon><infon key="source">Clin Microbiol Infect</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2014</infon><offset>25145</offset><text>ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.</text></passage><passage><infon key="fpage">1070</infon><infon key="lpage">2</infon><infon key="name_0">surname:Horowitz;given-names:ID</infon><infon key="name_1">surname:Blumberg;given-names:EA</infon><infon key="name_2">surname:Krevolin;given-names:L</infon><infon key="pub-id_pmid">8367759</infon><infon key="section_type">REF</infon><infon key="source">South Med J</infon><infon key="type">ref</infon><infon key="volume">86</infon><infon key="year">1993</infon><offset>25255</offset><text>Cryptococcus albidus and mucormycosis empyema in a patient receiving hemodialysis.</text></passage></document>
</collection>